These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 8104682)

  • 1. Taxol in combination with doxorubicin or etoposide. Possible antagonism in vitro.
    Hahn SM; Liebmann JE; Cook J; Fisher J; Goldspiel B; Venzon D; Mitchell JB; Kaufman D
    Cancer; 1993 Nov; 72(9):2705-11. PubMed ID: 8104682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Etoposide and doxorubicin antagonize the in vitro activity of paclitaxel in human non-small cell lung cancer cell lines.
    Viallet J; Tsao MS; Gallant G
    Lung Cancer; 1996 Aug; 15(1):93-101. PubMed ID: 8865127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of selenium in combination with Adriamycin or Taxol on several different cancer cells.
    Vadgama JV; Wu Y; Shen D; Hsia S; Block J
    Anticancer Res; 2000; 20(3A):1391-414. PubMed ID: 10928049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combinations of paclitaxel and etoposide in the treatment of lung cancer.
    Perez EA; Buckwalter CA; Reid JP
    Semin Oncol; 1996 Dec; 23(6 Suppl 15):21-5. PubMed ID: 8996593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequence dependence of paclitaxel (Taxol) combined with cisplatin or alkylators in human cancer cells.
    Liebmann JE; Fisher J; Teague D; Cook JA
    Oncol Res; 1994; 6(1):25-31. PubMed ID: 7919549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic interactions between stathmin inhibition and chemotherapeutic agents in prostate cancer.
    Mistry SJ; Atweh GF
    Mol Cancer Ther; 2006 Dec; 5(12):3248-57. PubMed ID: 17172428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative in vitro cytotoxicity of taxol and Taxotere against cisplatin-sensitive and -resistant human ovarian carcinoma cell lines.
    Kelland LR; Abel G
    Cancer Chemother Pharmacol; 1992; 30(6):444-50. PubMed ID: 1356649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity- and schedule-dependent interactions of paclitaxel, etoposide and hydroperoxy-ifosfamide in cisplatin-sensitive and -refractory human ovarian carcinoma cell lines.
    Klaassen U; Harstrick A; Schleucher N; Vanhoefer U; Schröder J; Wilke H; Seeber S
    Br J Cancer; 1996 Jul; 74(2):224-8. PubMed ID: 8688325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of doxycycline with chemotherapeutic agents in human breast adenocarcinoma MDA-MB-231 cells.
    Foroodi F; Duivenvoorden WC; Singh G
    Anticancer Drugs; 2009 Feb; 20(2):115-22. PubMed ID: 19209028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphatidylinositol 3-kinases inhibitor LY294002 potentiates the cytotoxic effects of doxorubicin, vincristine, and etoposide in a panel of cancer cell lines.
    Badinloo M; Esmaeili-Mahani S
    Fundam Clin Pharmacol; 2014 Aug; 28(4):414-22. PubMed ID: 23837575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of the antitumor activity of chemotherapeutic drugs by the hypoxic cytotoxic agent tirapazamine.
    Dorie MJ; Brown JM
    Cancer Chemother Pharmacol; 1997; 39(4):361-6. PubMed ID: 9025778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination treatment with fulvestrant and various cytotoxic agents (doxorubicin, paclitaxel, docetaxel, vinorelbine, and 5-fluorouracil) has a synergistic effect in estrogen receptor-positive breast cancer.
    Ikeda H; Taira N; Nogami T; Shien K; Okada M; Shien T; Doihara H; Miyoshi S
    Cancer Sci; 2011 Nov; 102(11):2038-42. PubMed ID: 21801281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective tumor sensitization to taxanes with the mAb-drug conjugate cBR96-doxorubicin.
    Wahl AF; Donaldson KL; Mixan BJ; Trail PA; Siegall CB
    Int J Cancer; 2001 Aug; 93(4):590-600. PubMed ID: 11477565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic synergy between flavopiridol (NSC 649890, L86-8275) and various antineoplastic agents: the importance of sequence of administration.
    Bible KC; Kaufmann SH
    Cancer Res; 1997 Aug; 57(16):3375-80. PubMed ID: 9269999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Fucoidan and Chemotherapeutic Agent Combinations on Malignant and Non-malignant Breast Cell Lines.
    Abudabbus A; Badmus JA; Shalaweh S; Bauer R; Hiss D
    Curr Pharm Biotechnol; 2017; 18(9):748-757. PubMed ID: 29141543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hesperetin-etoposide combinations induce cytotoxicity in U2OS cells: Implications on therapeutic developments for osteosarcoma.
    Coutinho L; Oliveira H; Pacheco AR; Almeida L; Pimentel F; Santos C; Ferreira de Oliveira JM
    DNA Repair (Amst); 2017 Feb; 50():36-42. PubMed ID: 28063664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactivity of monoclonal antibody FC-2.15 against drug resistant breast cancer cells. Additive cytotoxicity of adriamycin and taxol with FC-2.15.
    Ballaré C; Portela P; Schiaffi J; Yomha R; Mordoh J
    Breast Cancer Res Treat; 1998 Jan; 47(2):163-70. PubMed ID: 9497104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Schedule-dependent interaction between paclitaxel and doxorubicin in human cancer cell lines in vitro.
    Akutsu M; Kano Y; Tsunoda S; Suzuki K; Yazawa Y; Miura Y
    Eur J Cancer; 1995 Dec; 31A(13-14):2341-6. PubMed ID: 8652267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers.
    Pegram M; Hsu S; Lewis G; Pietras R; Beryt M; Sliwkowski M; Coombs D; Baly D; Kabbinavar F; Slamon D
    Oncogene; 1999 Apr; 18(13):2241-51. PubMed ID: 10327070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Schedule-dependent potentiation of chemotherapeutic drugs by the bioreductive compounds NLCQ-1 and tirapazamine against EMT6 tumors in mice.
    Papadopoulou MV; Ji M; Bloomer WD
    Cancer Chemother Pharmacol; 2001 Aug; 48(2):160-8. PubMed ID: 11561782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.